TheGlobal In Vitro Lung Model Market size was valued at USD 166 million in2019 and is expected to reach USD $483 million by 2026, at a CAGR of 18.2%during the forecast period.
The report includes an analysis of the impact of COVID-19lockdown on the revenue of market leaders, followers, and disruptors. Since thelockdown was implemented differently in various regions and countries; theimpact of the same is also seen differently by regions and segments. The reporthas covered the current short-term and long-term impact on the market, and itwould help the decision-makers to prepare the outline and strategies forcompanies by region.
Global In Vitro Lung Model Market Overview:
In vitro models of the human lung are also likely to providepowerful platforms for large-scale screens, molecular-level analysis ofcell-cell interactions, and the potential to study or treat lung disorders withpersonalized medicine.
The report covers the current estimate and forecast for inVitro Lung Model Market on a global and regional level. The report provides anin-depth analysis of the In Vitro Lung Model Market for the period 2019 – 2026,wherein 2019 is the base year and the period from 2020 to 2026 is the forecastperiod. Data for 2016- 2018 has been included as historical information.
The study provides a detailed perspective on market growth,throughout the forecast period in terms of revenue estimates (in US$ MN),across different geographies, which include North America (NA), Europe (EU),Asia Pacific (APAC), Middle East & Africa (MEA) and Latin America (LATAM).
The report provides qualitative and quantitative insights onthe In Vitro Lung Model industry trends and a detailed analysis of the marketsize and growth rate of all segments in the market. The market is segmented byType, Application, and Region.
Key players covered in the report of global in vitro lungmodel market are Epithelix, MatTek Corporation, Lonza, ATCC, InSphero, Emulate,AlveoliX AG, Oncotheis, Insphero, TissUse, Mimetas, CN Bio Innovations, ThermoFisher Scientific Inc., PromoCell GmbH, Merck KGaA, Hoziron Discovery Groupplc.
In Vitro Lung Model Market Dynamics:
Many differences between animal and human lung physiology,create an unmet need for human lung model systems that can complement animalmodels to improve our understanding of human lung physiology. Upsurgepopulation suffering from lung fibrosis & emphysema, lung cancer, and otherrespiratory disorders led the research into in vitro lung model.
The ability of in vitro lung model to relate and accuratelyrecapitulate complexities of human biology is to create the opportunities forthe growth of global market by improving the understanding for cell mechanism.Hence, this in vitro lung model increases the ability to treat patients havinglung diseases. Growing interest of scientists in cell biology and biochemistrystudy acts as a driver for growth of the global in-vitro lung model market.
2D Cell Model segment commanded the largest market share fortheir positive results in treatment of bronchiectasis and pulmonary functiondisorders.
Global In Vitro Lung Model Market
The powerful research in the cell-cell interaction inin-vitro lung models creates opportunities for the global in vitro lung modelmarket in the forecast period. 2D cell lung model examines cell-basedresponses, physiologic functions, drug toxicity, and drug responses, which ledto the growth of the global market results in a growing number of treatmentsand surgeries for lung diseases.
The drug screening & toxicology segment is expected toexpand at a significant CAGR of 9.0% during the forecast period.
An increase in research and development of new drugs andrising demand for in vitro lung models for lung transplantation are anticipatedto grow the global market. Government facilities and expenditure for researchand development across the pharmaceutical sector, biochemistry labs, nationalcell science centers are also boosting the global long model market. Humanmodel systems that reliably and accurately recapitulate the complexities ofhuman biology in vitro should help to improve our understanding of and abilityto treat human lung disease.
Europe commanded the largest market share of xx % by 2026.
Global In Vitro Lung Model Market 1
Europe commanded the largest market share of XX % during theforecast period for their availability of lots of literature studies for invitro lung models. An increase in research funding from various organizationsand a rise in research and development activities by various pharmaceutical andbiotechnology companies propel the growth of the global in-vitro lung modelmarket in Europe. Rising cases of asthma, lung cancer, and COPD are the majorfactors driving in vitro lung model market.
Global In Vitro Lung Model Market 2
Key Players Covered in the Global in Vitro Lung Model Market
• MatTek Corporation
• AlveoliX AG
• CN Bio Innovations
• Thermo Fisher Scientific Inc.
• PromoCell GmbH
• Merck KGaA
• Hoziron Discovery Group plc
For More Information Vist : https://www.maximizemarketresearch.com/market-report/global-in-vitro-lung-model-market/85854/
Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research of reports as per your demand. Thisreport can be personalized to meet your requirements. Get in touch with us andour sales team will guarantee provide you to get a report that suits yournecessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on20,000 high growth emerging opportunities & technologies as well as threatsto the companies across the Healthcare, Pharmaceuticals, Electronics & C
ommunications, Internet of Things, Food and Beverages,Aerospace and Defense and other manufacturing sectors.